Dates: 6th – 8th October 2025
Location: Basel, Switzerland
Link to Official Event Website: https://www.terrapinn.com/conference/biotechx/
Join Metabolon at BiotechX Europe 2025
Metabolon is attending the 2025 BiotechX Europe Congress, Europe’s largest congress for diagnostics, precision medicine, and digital transformation in biopharma. This premier event brings together scientists, clinicians, regulators, and technology leaders to drive innovation at the intersection of multi-omics, AI, and healthcare delivery.
You will find Metabolon’s team in Booth 728. As leaders in metabolomics and multiomics integration, we’re excited to engage with global biotech professionals driving the future of drug discovery, diagnostics, and data-driven healthcare.
Visit us at Messe Basel to explore how metabolomics delivers actionable insights that accelerate therapeutic development and precision health strategies across a wide range of disease areas.
Key Themes at BiotechX Europe 2025
BiotechX Europe 2025 will showcase innovative research and emerging technologies across key focus areas such as:
• Multi-Omics for Clinical Translation — Integration of genomics, proteomics, metabolomics, and transcriptomics to guide therapeutic development and clinical decision-making.
• AI & Data Science in Life Sciences — Application of machine learning, predictive analytics, and digital biomarkers to drug discovery and diagnostics.
• Next-Generation Diagnostics — Advancements in non-invasive and molecular diagnostics, companion diagnostics, and biomarker panels.
• Personalized Medicine & Patient-Centricity — Strategies for individualized therapy and real-world data implementation in clinical care.
• Metabolomics in Precision Health — The role of metabolism and biomarkers in advancing disease understanding, treatment response, and real-time biological insights.
Metabolomics plays a critical role across these themes by enabling a dynamic understanding of health and disease states, translating biological complexity into meaningful diagnostics and targeted therapeutic strategies.
The Role of Metabolomics in Precision Medicine & Omics Integration
As the biochemical layer most closely tied to phenotype, metabolomics enables researchers to move beyond genomics and transcriptomics to understand functional biology in real time.
Metabolon supports biotech and pharmaceutical innovators by:
- Revealing metabolic pathways driving disease mechanisms
- Identifying novel biomarkers for efficacy, safety, and response
- Supporting target validation and mechanism-of-action studies
- Enhancing patient stratification and companion diagnostics
- Enabling early detection and progression monitoring
Metabolomics plays a critical role in reducing development risk, accelerating timelines, and maximizing translational insight from discovery through clinical trials.
Find out more:
BiotechX Europe 2025 Featured Sessions
Explore sessions aligned with Metabolon’s areas of expertise, including:
- Multiomics & Biomarker Discovery
Advances in integrating metabolomics with genomics, proteomics, and microbiome data to uncover biomarkers with functional impact. - Clinical & Translational Research
Case studies demonstrating the power of metabolomics in stratifying patient populations, monitoring therapeutic efficacy, and identifying metabolic drivers of disease. - AI in Drug Development
How advanced analytics are reshaping interpretation of complex multiomic data to inform faster and more accurate decision-making.
Don’t miss out on our poster:
Poster number: 29
Title: Advancing Drug Discovery through Metabolomics-Driven Multiomics Integration
Why Visiting Metabolon’s Booth at BiotechX Europe 2025
Whether you’re focused on preclinical discovery or clinical development, the Metabolon team is here to help you harness the full potential of metabolomics.
At our booth, you can:
- Discuss your research or clinical objectives with our scientific team
- Learn how our global metabolomics platform delivers unmatched data quality and biological interpretation
- Explore real-world case studies across oncology, neurology, immunology, gastroenterology, and more
- Discover how multiomics integration is driving a new era of personalized medicine
We invite you to schedule a meeting or stop by to see how Metabolon can accelerate your science.
Visit us at Booth 728 to discover how our biology-first approach reveals novel, clinically actionable biomarkers that drive precision medicine forward.
Meet Metabolon’s Team at BiotechX Europe 2025
Kieran Jones, Strategic Account Manager, International.
With a scientific background in immunology and clinical development, he spent several years in pharma and CDMO roles at UCB and Lonza before transitioning into commercial. At Metabolon, he helps biopharma partners integrate metabolomics into their drug development, clinical, and manufacturing programs to accelerate decision-making and biomarker-driven strategy.
Joe Foster, Director of Strategic Products.
With 15+ years of bioinformatics expertise across genomics, proteomics, lipidomics, and metabolomics, Joe currently the roadmap for the Integrated Bioinformatics Platform (IBP)and develops Bioinformatics Professional Services to accelerate insights through scalable multiomics solutions. Formerly with Affymetrix, Thermo Fisher, and DNAnexus, Joe is passionate about advancing the idea that multiomics without metabolomics only scratches the surface of biological complexity.
With a PhD in Bioinformatics from the University of Cambridge and the European Bioinformatics Institute, Joe combines a strong scientific foundation with a practical, results-oriented approach to integrating metabolomics data into the broader multiomics landscape.
Joseph McGinley, Senior Bioinformatician.
With seven years of experience applying bioinformatics methods to answer biological questions. Joseph is a member of Metabolon’s bioinformatics team and currently works on the development of Metabolon’s visualization platform along with providing bioinformatics support for internal research initiatives.
Schedule a meeting with our team using the contact form on this page, to explore how metabolomics can inform your research goals.
Quick Links to Learn More About BioTechX
